# A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.

> **NCT00077623** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 572 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** epoetin alfa or beta
- **DRUG:** methoxy polyethylene glycol-epoetin beta (Mircera)
- **DRUG:** methoxy polyethylene glycol-epoetin beta (Mircera)

## Key facts

- **NCT ID:** NCT00077623
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 572 (ACTUAL)
- **Last updated:** 2016-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077623, "A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00077623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*